Upppp_老虎社区_美港股上老虎

sebsebseb
2021-06-24

Upppp

OCUGEN INVESTOR ALERT: Shareholder Lawsuit Filed

BOSTON, MA / ACCESSWIRE / June 21, 2021 / The Thornton Law Firm alerts investors that a class action

OCUGEN INVESTOR ALERT: Shareholder Lawsuit Filed

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":121517418,"tweetId":"121517418","gmtCreate":1624475324134,"gmtModify":1634005608840,"author":{"id":3575086147705955,"idStr":"3575086147705955","authorId":3575086147705955,"authorIdStr":"3575086147705955","name":"sebsebseb","avatar":"https://static.tigerbbs.com/a70738548d3d86c371165e9cdedeaa99","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Upppp</p></body></html>","htmlText":"<html><head></head><body><p>Upppp</p></body></html>","text":"Upppp","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/121517418","repostId":2145768039,"repostType":2,"repost":{"id":"2145768039","kind":"news","pubTimestamp":1624305600,"share":"https://www.laohu8.com/m/news/2145768039?lang=&edition=full","pubTime":"2021-06-22 04:00","market":"us","language":"en","title":"OCUGEN INVESTOR ALERT: Shareholder Lawsuit Filed","url":"https://stock-news.laohu8.com/highlight/detail?id=2145768039","media":"ACCESSWIRE","summary":"BOSTON, MA / ACCESSWIRE / June 21, 2021 / The Thornton Law Firm alerts investors that a class action","content":"<html><body><p><strong>BOSTON, MA / ACCESSWIRE / June 21, 2021 /</strong> The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Ocugen, Inc. (NASDAQ:OCGN). The case is currently in the lead plaintiff stage. Investors who purchased OCGN stock or other securities between February 2, 2021 and June 10, 2021 may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Ocugen for more information. Investors may also email investors@tenlaw.com or call 617-531-3917.</p>\n<img src=\"https://s1.yimg.com/uu/api/res/1.2/mqLJ.C9W9pFLvf715OGSmw--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/accesswire.ca/c7a3b2e0d9f1a11cd6634341bda24637\"/>\n<p>FOR MORE INFORMATION: www.tenlaw.com/cases/Ocugen</p>\n<p>The case alleges that Ocugen and its senior executives made misleading statements to investors and failed to disclose that: (i) the information that Ocugen submitted to the U.S. Food and Drug Administration (\"FDA\") was insufficient to support an Emergency Use Authorization (\"EUA\"); and (ii) Ocugen would not file an EUA with the FDA.</p>\n<p>Interested Ocugen investors have until August 17, 2021 to retain counsel and apply to be a lead plaintiff if they are interested to do so. A lead plaintiff acts on behalf of all other investor class members in managing the class action. Investors do not need to be a lead plaintiff in order to be a class member. If investors choose to take no action, they can remain an absent class member. The class has not yet been certified. Until certification occurs, investors are not represented by an attorney. Thornton Law Firm is not currently representing a plaintiff who filed a complaint but is investigating the case on behalf of investors interested in being a lead plaintiff.</p>\n<p>FOR MORE INFORMATION: www.tenlaw.com/cases/Ocugen</p>\n<p>Thornton Law Firm's securities attorneys are highly experienced in representing investors in recovering damages caused by violations of the securities laws. Its attorneys have established track records litigating securities cases in courts throughout the country and recovering losses on behalf of investors. This may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee or predict a similar outcome with respect to any future matter.</p>\n<p><strong>CONTACT:</strong><br/>Thornton Law Firm LLP<br/>1 Lincoln Street<br/>State Street Financial Center<br/>Boston, MA 02111</p>\n<p>www.tenlaw.com/cases/Ocugen</p>\n<p><strong>SOURCE: </strong>Thornton Law Firm LLP</p>\n<br/>\n<br/>View source version on accesswire.com: \n<br/>\nhttps://www.accesswire.com/652560/OCUGEN-INVESTOR-ALERT-Shareholder-Lawsuit-Filed\n<br/>\n<br/>\n<img height=\"0\" src=\"https://www.accesswire.com/img.ashx?id=652560\" width=\"0\"/></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OCUGEN INVESTOR ALERT: Shareholder Lawsuit Filed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOCUGEN INVESTOR ALERT: Shareholder Lawsuit Filed\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-22 04:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/ocugen-investor-alert-shareholder-lawsuit-200000687.html><strong>ACCESSWIRE</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BOSTON, MA / ACCESSWIRE / June 21, 2021 / The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Ocugen, Inc. (NASDAQ:OCGN). The case is currently ...</p>\n\n<a href=\"https://finance.yahoo.com/news/ocugen-investor-alert-shareholder-lawsuit-200000687.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/rV.SVOf.fSvuCtY32DMuZw--~B/aD03ODt3PTMwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/Ou0Q5rJmDqIAq0wjQnhE3A--~B/aD03ODt3PTMwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/accesswire.ca/c7a3b2e0d9f1a11cd6634341bda24637","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://finance.yahoo.com/news/ocugen-investor-alert-shareholder-lawsuit-200000687.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145768039","content_text":"BOSTON, MA / ACCESSWIRE / June 21, 2021 / The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Ocugen, Inc. (NASDAQ:OCGN). The case is currently in the lead plaintiff stage. Investors who purchased OCGN stock or other securities between February 2, 2021 and June 10, 2021 may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Ocugen for more information. Investors may also email investors@tenlaw.com or call 617-531-3917.\n\nFOR MORE INFORMATION: www.tenlaw.com/cases/Ocugen\nThe case alleges that Ocugen and its senior executives made misleading statements to investors and failed to disclose that: (i) the information that Ocugen submitted to the U.S. Food and Drug Administration (\"FDA\") was insufficient to support an Emergency Use Authorization (\"EUA\"); and (ii) Ocugen would not file an EUA with the FDA.\nInterested Ocugen investors have until August 17, 2021 to retain counsel and apply to be a lead plaintiff if they are interested to do so. A lead plaintiff acts on behalf of all other investor class members in managing the class action. Investors do not need to be a lead plaintiff in order to be a class member. If investors choose to take no action, they can remain an absent class member. The class has not yet been certified. Until certification occurs, investors are not represented by an attorney. Thornton Law Firm is not currently representing a plaintiff who filed a complaint but is investigating the case on behalf of investors interested in being a lead plaintiff.\nFOR MORE INFORMATION: www.tenlaw.com/cases/Ocugen\nThornton Law Firm's securities attorneys are highly experienced in representing investors in recovering damages caused by violations of the securities laws. Its attorneys have established track records litigating securities cases in courts throughout the country and recovering losses on behalf of investors. This may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee or predict a similar outcome with respect to any future matter.\nCONTACT:Thornton Law Firm LLP1 Lincoln StreetState Street Financial CenterBoston, MA 02111\nwww.tenlaw.com/cases/Ocugen\nSOURCE: Thornton Law Firm LLP\n\nView source version on accesswire.com: \n\nhttps://www.accesswire.com/652560/OCUGEN-INVESTOR-ALERT-Shareholder-Lawsuit-Filed","news_type":1},"isVote":1,"tweetType":1,"viewCount":812,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}